CompletedNot Applicable

Comparing Interventions for Indoor Air -Related Functional Symptoms

Finland75 participantsStarted 2014-02

Plain-language summary

The aim of the current study is to compare the effictiveness of three different psychosocial therapies for treating functional disorders caused by indoor air problems.

Who can participate

Age range25 Years – 58 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Self-assessed work ability not more than 7 (on a scale 0-10, compared to lifetime best) (removed, see below)
✓. Employed minimum three (3) or more years
✓. Symptoms related to work environment indoor air (non-industrial workplaces)
✓. Respiratory symptoms related to indoor air
✓. And symptoms involve more than one other organ system
✓. Symptoms onset maximum three years before the study
✓. Symptoms are recurrent
✓. Symptoms appear more than one (1) environment or continue after repairs environmental exposure(s)

Exclusion criteria

✕. six (6) months or more sick leave sick leaves due to indoor air symptoms during the preceding two years and currently unable to work
✕. Planned changes in the work (for example retirement, study free period, pregnancy etc.) during the study
✕. An acute, untreated medical disorder or illnesses:
✕. Somatic disease that explains the symptoms
✕. An acute, untreated mental disorder (depression, bipolar disorder, psychotic disorders, obsessive-compulsive disorder, eating disorders, personality disorders)
✕. Abuse of narcotics or alcohol or (non-prescribed) medicine
✕. Developmental disorders
✕. Psychotherapy (current or has ended preceding two years)

What they're measuring

15D - instrument

Timeframe: baseline, 3, 6 and 12 months from the baseline

Trial details

NCT IDNCT02069002

SponsorFinnish Institute of Occupational Health

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2018-07-29

View on ClinicalTrials.gov More Environmental Illness trials